Cross John Harry Iii Insider Trades

Insider Trading History

Track insider trading activity for Cross John Harry Iii. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Senti Biosciences
Senti Biosciences SNTI
Chief Financial Officer
Holding Value $174k 174,200 shares
Last Trade
Mar 07, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$613k 174,200 shares
$3.52
$1.00
Sonnet BioTherapeutics Holdings
Sonnet BioTherapeutics Holdings SONN
Chief Financial Officer
Holding Value $2k 1,588 shares
Last Trade
Dec 11, 2023 Sale (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$16.8k 1,452 shares
$11.59
$1.26
Sonnet BioTherapeutics Holdings
Sonnet BioTherapeutics Holdings SONN
Chief Financial Officer
Holding Value $30.1k 23,927 shares
Last Trade
Feb 06, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$365k 1,960 shares
$186.37
$1.26
Sonnet BioTherapeutics Holdings
Sonnet BioTherapeutics Holdings SONN
Chief Financial Officer
Holding Value $202k 160,684 shares
Last Trade
Dec 14, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.73M 15,519 shares
$175.82
$1.26
Sonnet BioTherapeutics Holdings
Sonnet BioTherapeutics Holdings SONN
Chief Financial Officer
Holding Value $183k 145,165 shares
Last Trade
Dec 15, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$83M 66,951 shares
$1,239.38
$1.26
Sonnet BioTherapeutics Holdings
Sonnet BioTherapeutics Holdings SONN
Chief Financial Officer
Holding Value $98.5k 78,214 shares
Last Trade
Jul 02, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$699M 78,214 shares
$8,935.38
$1.26

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up